2-Formylpyridyl Ureas as Highly Selective Reversible-Covalent Inhibitors of Fibroblast Growth Factor Receptor 4-Reference-Cited by-同舟云学术

2-Formylpyridyl Ureas as Highly Selective Reversible-Covalent Inhibitors of Fibroblast Growth Factor Receptor 4

Published:2018-02-01 Issue:3 Volume:9 Page:215-220
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Knoepfel Thomas¹,Furet Pascal¹,Mah Robert¹,Buschmann Nicole¹,Leblanc Catherine¹,Ripoche Sebastien¹,Graus-Porta Diana¹,Wartmann Markus¹,Galuba Inga¹,Fairhurst Robin A.¹^ORCID

Affiliation:

1. Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.7b00485

Reference17 articles.

1. Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction

2. Targeting the Fibroblast Growth Factor Receptors for the Treatment of Cancer

3. Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma

4. Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge region

5. Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update;Journal of Medicinal Chemistry;2024-05-07

2. Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on S_NAr Electrophiles;Journal of Medicinal Chemistry;2024-04-11

3. Design, synthesis, and biological evaluation of selective covalent inhibitors of FGFR4;European Journal of Medicinal Chemistry;2024-03

4. Insight into the design of FGFR4 selective inhibitors in cancer therapy: Prospects and challenges;European Journal of Medicinal Chemistry;2024-01

5. Insight into Structure-Activity Relationship of New Compounds for Breast Cancer Treatment;Current Topics in Medicinal Chemistry;2023-10